E. Takahashi et al., ANGIOTENSIN-II STIMULATES P90(RSK) IN VASCULAR SMOOTH-MUSCLE CELLS - A POTENTIAL NA-H+ EXCHANGER KINASE(), Circulation research, 81(2), 1997, pp. 268-273
Angiotensin II is a multifunctional agonist for vascular smooth muscle
cells (VSMCs), stimulating increases in signal events, cell growth, a
nd ion flux. We previously defined protein kinase C (PKC)-dependent an
d -independent mechanisms by which angiotensin II stimulated activity
of the Na+-H- exchanger isoform-1 (NHE-1) and identified a 90-kD kinas
e that exhibited increased activity in VSMCs isolated from genetically
hypertensive rats. To determine whether this 90-kD kinase was p90(rsk
) (RSK), VSMCs were stimulated with 100 nmol/L angiotensin II, and NHE
-1 kinase activity was measured by phosphorylation of recombinant NHE-
1 (a glutathione S-transferase fusion protein containing amino acids 5
16 to 815 of the cytoplasmic carboxyl tail) in vitro. NHE-1 kinase (90
kD) activity was markedly decreased by immunodepletion of RSK. Charac
terization of RSK activation by angiotensin II revealed many similarit
ies to the 90-kD NHE-1 kinase, including time course and NHE-1 domain
phosphorylation, as well as regulation by extracellular signal-regulat
ed kinases (ERK1/2), intracellular Ca2+, and PKC. Specifically, angiot
ensin II stimulated a rapid and transient (peak, 5 minutes) increase i
n RSI( activity. Analysis of several NHE-1 fusion proteins revealed th
at only proteins containing amino acids 678 to 714 were phosphorylated
by RSK. Inhibiting ERK1/2 (30 mu mol/L PD09S059 for 30 minutes) or ch
elating intracellular Ca2+ prevented RSK activation. In contrast, down
regulating PKC (1 mu mol/L phorbol dibutyrate for 74 hours) had little
effect. These findings establish RSI( as a putative NHE-1 kinase and
potential mediator of increased Na+-H+ exchange in hypertension.